Nicolas M Van Mieghem

Nicolas M Van Mieghem

Medical Director

Thoraxcenter, Erasmus University Medical Center, Rotterdam, the Netherlands

  • LinkedIn
  • Twitter
  • Radcliffe
  • OrcidID

Biography

Personal History

From an early age, Professor Nicolas Maria Van Mieghem decided to pursue a career that would help others. “I enjoy the feeling of being able to help someone or do something important for them. I wanted to enter a profession that would channel my energy— I was always a busy child,” he says. 

A budding athlete, he was a member of Belgium’s national swimming team but soon realized that medicine was his true calling. His father was a general cardiologist and one of his biggest influences early in his career.

Professor Van Mieghem initially intended to train as a cardiac surgeon but decided to specialise in interventional cardiology instead, following advice from a mentor. This decision was cemented when he read the first-in-human case report of transcatheter aortic valve implantation (TAVI) in Circulation by Alain Cribier in 2002. 

His mantra is mens sana in corpore sano (a healthy mind in a healthy body). He remains an avid swimmer and cyclist and follows a number of professional sports. “Like all Belgians, I love to watch the big cycling events—the classic cycle races, the Tour de France, the Giro d’Italia, the Vuelta a España,” he says. 

Van Mieghem believes that a great cardiologist genuinely cares for their patients. He names Gary Roubin, Dr Manu Malbrain and Professor Patrick Serruys among his mentors. 


 

Academic History

 

In 2007, Professor Van Mieghem obtained his medical and cardiology degrees at the Catholic University of Leuven, Belgium. He completed fellowships in interventional cardiology in Ziekenhuis Oost-Limburg Genk, Belgium, Lenox Hill Hospital, New York, US and Erasmus Medical Center, Rotterdam, the Netherlands.2 His PhD focused on transcatheter valve therapies.3

His current research focuses on cerebral embolic protection during TAVI and the search for improved large bore closure devices. He works actively in expanding TAVI indications, most notably TAVI as a means to further unload the left ventricle in heart failure patients with moderate aortic stenosis (the TAVR UNLOAD trial). Professor Van Mieghem is also involved in the development and dispersion of mechanical circulatory support (MCS) devices as well as transcatheter mitral and tricuspid repair techniques. In terms of imaging and preprocedural planning, his research has covered computed tomography (CT)-derived 3D modelling and printing.

Professor Van Mieghem has received institutional research grant support from Abbott Vascular, Boston Scientific, Edwards Lifesciences, Medtronic, Daiichi-Sankyo, PulseCath BV and Abiomed.7

 

Career Overview

After his fellowships, Professor Van Mieghem joined the department of interventional cardiology at the Thorax Centre, Erasmus Medical Center, as a senior staff member in February 2010. He is now working there as a Full Professor of Interventional Cardiology.2

As well as his involvement in the percutaneous coronary interventions and structural heart programs, he has published and co-authored over 350 scientific papers in peer-reviewed journals.4 Professor Van Mieghem is a principal investigator and steering committee member in multiple ongoing international trials, evaluating various coronary and transcatheter valve technologies.3 He is a Fellow of the European Society of Cardiology (FESC) and is currently Medical Director of the department of Interventional cardiology at the Thorax Centre.3

 

Career Timeline

  • 2008 - 2009: Fellow, Interventional Cardiology, Lenox Hill Hospital
  • 2010: Joined the senior staff, Interventional Cardiology, Thorax Centre, Erasmus MC
  • 2014: Clinical Director, Interventional Cardiology, Erasmus MC
  • 2019 - Present: Full Professor, Interventional Cardiology, Erasmus MC
  • Present: Medical Director, Interventional Cardiology, Thorax Centre 

 

Areas of Speciality4

  • Interventional Cardiology
  • Transcatheter Heart Valve Interventions

 

Sources

  1. https://cardiovascularnews.com/nicolas-van-mieghem/
  2. https://esc365.escardio.org/Person/418700-dr-van-mieghem-nicolas 
  3. https://www.radcliffecardiology.com/authors/nicolas-m-van-mieghem 
  4. https://www.ecri-trials.com/faculty/nicolas-van-mieghem/ 
  5. https://www.cardialysis.com/core-lab/supervising-cardiologists/ 
  6. https://www.worldcat.org/title/transcatheter-aortic-valve-therapies-from-cutting-edge-to-mainstream-catheter-gebonden-aortaklep-implantatie/oclc/892053833 
  7. https://www.jacc.org/doi/pdf/10.1016/j.jcin.2020.12.021 

 

 Prof Van Mieghem is on the ICR3 Editorial Board.

 

Media

Articles by Nicolas M Van Mieghem, Medical Director

Precision Medicine in Interventional Cardiology

Thijmen W Hokken, Joana M Ribeiro, Peter P De Jaegere, et al

Published:

Citation: Interventional Cardiology Review 2020;15:e03.

Aortic Stenosis and Heart Failure: Disease Ascertainment and Statistical Considerations for Clinical Trials

Ernest Spitzer, Rebecca T Hahn, Philippe Pibarot, et al

Published:

Citation: Cardiac Failure Review 2019;5(2):99–105.

Coronary Calcified Lesions: Introduction to the Focused Issue

Nicolas M Van Mieghem,

Published:

Citation: Interventional Cardiology Review 2019;14(3):152–3.

Large-bore Vascular Closure: New Devices and Techniques

Maarten P van Wiechen, Jurgen M Ligthart, Nicolas M Van Mieghem, et al

Published:

Citation: Interventional Cardiology Review 2019;14(1):17–21

The Role of Automated 3D Echocardiography for Left Ventricular Ejection Fraction Assessment

Ernest Spitzer, Ben Ren, Felix Zijlstra, et al

Citation: Cardiac Failure Review 2017;3(2):97–101.

Need for Embolic Protection During Transcatheter Aortic Valve Implantation: An Interventionalist’s Perspective on Histopathology Findings

Herbert G Kroon, Nicolas M Van Mieghem,

Citation: Interventional Cardiology Review 2017;12(1):36–9

Personal Experience with Bioresorbable Scaffolds in Bifurcations

Roberto Diletti, Nicolas M Van Mieghem,

Citation: Interventional Cardiology Review 2013;8(2):93-5

Cardiovascular Clinical Trials in a Pandemic: Immediate Implications of Coronavirus Disease 2019

Ernest Spitzer, Ben Ren, Jasper J Brugts, et al

Published:

Citation: Cardiac Failure Review 2020;6:e09.

A42 - Pressure and Volume Unloading with Pulsatile Circulatory Support During High-risk Percutaneous Revascularisation

MB Bastos, JJ Schreuder, Joost Daemen, et al

Published:

Citation: Interventional Cardiology Review 2019;14(3 Suppl 1):A42.